First Toronto Fire Services stations were hit with COVID-19 amongst vaccinated staff, now Toronto Police has been stung.
After suspended 205 staff for non-vaccination compliance to prevent spreading the virus, the service has now seen outbreaks a Traffic Services and 11 Division.
Concerned parent and outspoken activist, Vladislav Sobolev, delivered “important documents” to Toronto Police Chief James Ramer yesterday that cite the serious harms of the experimental mRNA shots to children.
The documents include the Toronto Sick Kids’ Hospital’s Myocarditis and pericarditis after mRNA Covid-19 vaccination in children: Interim guidance, the U.S. CDC’s Myopericarditis following COVID-19 vaccination: Updates from the Vaccine Adverse Event Reporting System (VAERS), and 2 documents sent to the Toronto City Council Dec. 6, 2021, Board of Health meeting, one from Dr. Rochagné Kilian, MD, and the other from Margot Boyd, ethical activist.
The Centers for Disease Control and Prevention (CDC) announced this week that its PCR test has failed its full review and will have its Emergency Use Authorization revoked because it cannot distinguish between COVID-19 and the Influenza Flu.
The Innova SARS-CoV-2 Antigen Rapid Qualitative Test, the CDC’s benchmark COVID diagnostic testing system, will be withdrawn for Emergency Use by the end of 2021 due to an inordinate frequency of false positive and negative results.
“The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death,” the FDA stated on its website.
“Labeling distributed with certain configurations of the test includes performance claims that did not accurately reflect the performance estimates observed during the clinical studies of the tests. The performance characteristics of the test have not been adequately established, presenting a risk of false results.”
The FDA goes on to explain the risks associated with false positives and negatives:
False-negative results may lead to delayed diagnosis or inappropriate treatment of SARS-CoV-2, which may cause patient harm including serious illness and death. False-negative results can also lead to further spread of the SARS-CoV-2 virus, including when presumed negative patients are grouped into cohorts in health care, long-term care, and other facilities based on false test results.
False-positive results could lead to a delay in the correct diagnosis and the initiation of an appropriate treatment for the actual cause of patient illness, which could be another life-threatening disease that is not SARS-CoV-2. False-positive results could also lead to further spread of the SARS-CoV-2 virus when presumed positive patients are grouped into cohorts based on false test results.
In April, the Innova Medical Group sent an Urgent Medical Device Recall letter to all affected device users.
“Do not use these tests to screen for or diagnose COVID-19,” the letter states.
“Either destroy the tests by placing them in the trash or return the tests using the FedEx return label that was included with the letter Innova sent to its customers.”
The CDC released a statement in response to the FDA’s recall, urging clinics to abandon the PCR test in favor of an “FDA-authorized” alternative.
“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only,” the CDC website states.
“CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.”
The PCR test, known as the bedrock of COVID diagnostic testing across the world, has been exposed as just another scam in the ongoing COVID hoax, but you can bet the mainstream media will ignore this extremely important development.
A document circulating online about apprehending unvaccinated people in Ontario appeared to be written by the Canadian minister of health Christine Elliott and Solicitor General Sylvia Jones but the document has been proven to be completely fake. Meanwhile secret quarantine facilities are still in operation all over Canada as the military is preparing to follow Australia’s lead when it comes to detaining and isolating anyone of their choosing all because of Covid-19(84). In this video Dan Dicks of Press For Truth explains why he thinks this document is a red hearing purposefully “leaked” by the Canadian military as part of their new initiative under their new organization that will use propaganda and other techniques to try to influence the attitudes, beliefs and behaviours of Canadians.
The Canadian military’s Joint Operations Command implemented a propaganda campaign in April 2020 with the intent to manipulate unsuspecting Canadians into falling in line with the federal government’s official positions on Covid-19. The brainwashing operation’s termination was ordered a month later, but in the meantime, it “relied on propaganda techniques similar to those employed during the Afghanistan war,” according to the Ottawa Citizen’s exclusive report on documents obtained under Access to Information.
The operation’s aim, according to the military, was to “head off civil disobedience by Canadians during the coronavirus pandemic and to bolster government messages about the pandemic.”
Fauci has been around a long time. He’s been director of the National Institute of Allergy and Infectious Diseases since 1984. And Fauci wasn’t just sitting around, waiting for this virus to thrust him into the global spotlight. He had a career. As head of NIAID, Fauci controls more than $6 billion in funding for scientific research. That’s enough money that Fauci, for decades, has shaped the very direction of medical research. Robert Kennedy reveals the full extent of Fauci’s sinister behavior in the early days of the AIDS crisis. He shows how Fauci sabotaged many low-cost treatments for the disease in favor of promoting a chemotherapy drug, AZT, as the only solution. AZT basically didn’t work, and instead killed a lot of the people taking it.
Importance Increased rates of myocarditis/pericarditis following COVID-19 mRNA vaccines have been observed. However, little data are available related to product-specific differences, which have important programmatic impacts.
Objective The objective of this study was to estimate reporting rates of myocarditis/pericarditis following COVID-19 mRNA vaccine by product, age, sex, and dose number, as well inter-dose interval.
Design We conducted a population-based cohort study using passive vaccine safety surveillance data. All individuals in Ontario, Canada who received at least one dose of COVID-19 mRNA vaccine between December 14, 2020 and September 4, 2021 were included.
Setting This study was conducted in Ontario, Canada (population: 14.7 million) using the provincial COVID-19 vaccine registry and provincial adverse events following immunization database.
Participants We included all individuals with a reported episode of myocarditis/pericarditis following COVID-19 vaccine in the study period. We obtained information on all doses administered in the province to calculate reporting rates.
Exposure Receipt of COVID-19 mRNA vaccine (mRNA-1273 [Moderna Spikevax] or BNT162b2 [Pfizer-BioNTech Comirnaty]).
Main Outcome(s) and Measure(s) Reported rate of myocarditis/pericarditis meeting level 1-3 of the Brighton Collaboration case definitions.
Results There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose of COVID-19 mRNA vaccine and 76.8% occurred in males. The median age of individuals with a reported event was 24 years. The highest reporting rate of myocarditis/pericarditis was observed in males aged 18-24 years following mRNA-1273 as the second dose; the rate in this age group was 5.1 (95% CI 1.9-15.5) times higher than the rate following BNT162b2 as the second dose. Overall reporting rates were higher when the inter-dose interval was shorter (i.e., ≤30 days) for both vaccine products. Among individuals who received mRNA-1273 for the second dose, rates were higher for those who had a heterologous as opposed to homologous vaccine schedule.
Conclusions and Relevance Our results suggest that vaccine product, inter-dose interval and vaccine schedule combinations may play a role in the risk of myocarditis/pericarditis, in addition to age and sex. Certain programmatic strategies could reduce the risk of myocarditis/pericarditis following mRNA vaccines.